Copyright 2009 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2009
Zhang et al1(p480) introduce their study about communication at the end of life by observing that “Life-sustaining medical care of patients with advanced cancer at the end of life (EOL) is costly.” However, their data suggest that such “life-sustaining” treatments do not prolong life, although they clearly show that such suffering-inducing treatments result in a poorer quality of death.
Workman S. Life Prolonging in Name Only?. Arch Intern Med. 2009;169(16):1540. doi:10.1001/archinternmed.2009.273
Customize your JAMA Network experience by selecting one or more topics from the list below.